Version:

02-04-2014 26-08-2014: Change in HPV schedule 31-08-2017: Schedule 2017/2018 publication 22-08-2019: Launch of the 2019/2020 vaccination schedule 04-11-2021: Updated recommendations for COVID-19 Vaccine 01-01-2023: 2023 vaccination calendar 12-04-2024: April 2024 version 12-02-2025: 2025 version

Footnotes:

1. https://www.rki.de/DE/Content/Infekt/Impfen/ImpfungenAZ/COVID-19/Impfempfehlung-Zusfassung.html
2. Premature infants receive an additional vaccine dose at the age of 3 months; in total they receive 4 doses
3. For more information on specific population groups where measles vaccination is mandatory please refer to https://www.masernschutz.de/themen/rechtliche-aspekte.html
4. TIV may also be replaced by QIV (quadrivalent) or aTIV (adjuvanted TIV) vaccine
5. Vaccine offered only to patients with risk factors.
6. Vaccination is also recommended for persons 6 months and older with increased health risk for a severe course of COVID-19 due to an underlying disease. For more information: https://www.rki.de/EN/Topics/Infectious-diseases/Immunisation/STIKO/STIKO-recommendations/Downloads/04_25_english.pdf
7. 3rd dose only for pentavalent rotavirus vaccines
8. Booster doses every 10 years. catch-up for those unvaccinated
9. The next due Td 10-yearly booster dose should be with a Tdacp vaccine. Subsequent booster doses are to be done with Td vaccines. Vaccination offered to pregnant women at the beginning of 3rd trimester. If there is an increased probability of premature birth, vaccination should be brought forward to the 2nd trimester. More information available at: RKI - Vaccinations A - Z - Scientific justification for recommending pertussis vaccination with a Tdap combination vaccine in pregnancy
10. optional dosis if monovalent and other combination vaccines are used
11. catch-up for those unvaccinated
12. number of doses necessary varies according to age
13. Introduction of MenB vaccine in January 2025
14. Vaccination from 9 months in specific circumstances. In this case, the second dose should be given as early as possible in the second year of life. The 'Measles Protection Act’ was approved in Germany and became effective on March 1st, 2020. It mandates measles vaccination for all children at one year and older that attend a childcare facility.
15. one dose of measles for those aged 18 years and older and born after 1970 with no vaccination or uncertain vaccination history or only one vaccination during childhood
16. Vaccination from 9 months in specific circumstances. In this case, the second dose should be given as early as possible in the second year of life.
17. 2 or 9-valent. Gender-neutral (boys and girls) vaccination offered since 2018. Two-dose schedule at 0 and 6 months (if the interval between doses is <6 months, a third dose is recommended).
18. 2 or 9 valent. Catch up in 15-17 years with a three-dose schedule.
19. Children/adolescence between the age of 6 month and 17 years with one or more medical condition or underlying disease, are recommended to receive seasonal influenza vaccination. Medical conditions or underlying diseases to consider are: -Chronic diseases of the respiratory tract, including asthma and chronic obstructive pulmonary disease (COPD) -Chronic cardiovascular, liver and kidney disease -Diabetes mellitus and other metabolic diseases -Chronic neurological diseases, e. g., multiple sclerosis with relapses triggered by infections -Congenital or acquired immunodeficiency -HIV infection More information is available at: https://www.rki.de/DE/Aktuelles/Publikationen/Epidemiologisches-Bulletin/2024/04_24.pdf?__blob=publicationFile&v=4
20. For more information: https://www.rki.de/EN/Topics/Infectious-diseases/Immunisation/STIKO/STIKO-recommendations/recommendations_content.html
21. 2 doses with a minimal and maximum interval of 2 to 6 months respectively between doses. Vaccination with the inactivated herpes zoster subunit vaccine. see recommendation background paper: https://link.springer.com/article/10.1007/s00103-019-02882-5

More information available at:
https://www.rki.de/DE/Content/Kommissionen/STIKO/Empfehlungen/Impfempfehlungen_node.html




---------------------------------------------------------------------------------------


01 March 2021: new measles mandatory vaccination requirements for specific population groups
https://www.masernschutz.de/themen/rechtliche-aspekte.html


---------------------------------------------------------------------------------------


22 August 2019: Launch of the 2019/2020 vaccination schedule

change include updated recommendation for Herpes-Zoster with an inactivated vaccine. see for more info: https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2018/Ausgaben/50_18.pdf%3F__blob%3DpublicationFile

---------------------------------------------------------------------------------------

31 August 2017: Publication of the 2017/2018 vaccination schedule
Changes include:
- A decision NOT to implement routine ZOSTER vaccination (immunisation is to be decided on a case-by-case basis)
- A revised policy for FLU vaccination of children aged 2-17 years
- For TETANUS post-exposure prophylaxis - ONLY recommended if a last dose was given more than 10 years ago. This applies to limited, clean wounds
- For HepA/HepB vaccination ; revision of the groups where vaccination is recommended

For more information, please refer to https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2017/Ausgaben/35_17.pdf?__blob=publicationFile
---------------------------------------------------------------------------------------


The German immunisation calendars in 16 foreign languages can be found here:
http://www.rki.de/DE/Content/Infekt/Impfen/Materialien/Impfkalender_mehrsprachig_Uebersicht_tab.html?nn=2709264

---------------------------------------------------------------------------------------

Recommendation for children with underlying medical conditions:
Vaccination recommendations for children with underlying medical conditions or specific health risks currently exist for the following diseases: Haemophilus influenzae type b, hepatitis A and B, influenza, meningococcal infections (groups A, C, W135, Y), and pneumococcal diseases. Specifics of those recommendations can be found in English at: www.stiko.de/en


---------------------------------------------------------------------------------------
Sept. 2023:
Pneumococcal vaccination: recommendation change for adults. see for more details: https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2023/Ausgaben/39_23.pdf?__blob=publicationFile


---------------------------------------------------------------------------------------

January 2025 Introduction of the MenB vaccine.

----------------------------------------------------------------------------------------

Date of last update: 12 February 2025